Seungho Lee, PhD

Co-Founder & CEO

Dr. Seungho Lee is the Co-founder and CEO of SUTOL Bio, and a visionary biomedical engineer dedicated to bridging the gap between breakthrough science and clinical reality. As a co-inventor of SUTOL's core gastric-resident technology at MIT's Langer and Traverso Labs, he has spent over six years evolving this academic innovation into a scalable, once-monthly oral platform. With a foundation of 20 patents and 45+ peer-reviewed publications, he is leading SUTOL Bio to redefine treatment adherence and fundamentally improve patient lives globally.